Pharmala Biotech Holdings Inc. (MDMA.CN)
CAD 0.23
(-4.17%)
CAD 0.23
(-4.17%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 454.09 Thousand CAD | 499.22% |
| 2022 | 75.78 Thousand CAD | 25110.56% |
| 2021 | -303.00 CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 74.64 Thousand CAD | -83.76% |
| 2024 Q1 | 459.51 Thousand CAD | 27.37% |
| 2024 Q3 | -141.19 Thousand CAD | -289.17% |
| 2023 Q2 | 80.15 Thousand CAD | 708.26% |
| 2023 Q1 | -13.17 Thousand CAD | -285.27% |
| 2023 Q3 | -13.17 Thousand CAD | -116.44% |
| 2023 FY | 454.09 Thousand CAD | 499.22% |
| 2023 Q4 | 360.76 Thousand CAD | 2837.62% |
| 2022 Q2 | -445.00 CAD | -75.89% |
| 2022 Q1 | -253.00 CAD | 0.0% |
| 2022 Q3 | 68.66 Thousand CAD | 15531.24% |
| 2022 FY | 75.78 Thousand CAD | 25110.56% |
| 2022 Q4 | 7113.00 CAD | -89.64% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 FY | -303.00 CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -50.39 Thousand CAD | 1001.026% |
| Asep Medical Holdings Inc | -113.74 Thousand CAD | 499.243% |
| BetterLife Pharma Inc. | - CAD | -Infinity% |
| BioVaxys Technology Corp. | - CAD | -Infinity% |
| ChitogenX Inc. | -42 Thousand CAD | 1181.188% |
| Rapid Dose Therapeutics Corp. | 563.4 Thousand CAD | 19.402% |
| Defence Therapeutics Inc. | -90.92 Thousand CAD | 599.427% |
| Entheon Biomedical Corp. | 250.32 Thousand CAD | -81.405% |
| Gemina Laboratories Ltd. | -93.36 Thousand CAD | 586.354% |
| Glow Lifetech Corp. | -505.62 Thousand CAD | 189.809% |
| Lexston Life Sciences Corp. | -26.39 Thousand CAD | 1820.463% |
| Doseology Sciences Inc. | -36.08 Thousand CAD | 1358.45% |
| MYND Life Sciences Inc. | -332.99 Thousand CAD | 236.37% |
| Nova Mentis Life Science Corp. | 25.4 Thousand CAD | -1687.439% |
| PharmaTher Holdings Ltd. | -711.00 CAD | 63967.651% |
| PreveCeutical Medical Inc. | -9856.00 CAD | 4707.336% |
| Telescope Innovations Corp. | 595.39 Thousand CAD | 23.732% |